Stay updated on Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial

Sign up to get notified when there's something new on the Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.6.6 is now shown instead of v3.6.5, indicating a new page build. This update does not alter the study details or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-08-29T18:59:45.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5 in the study documents section. This indicates an updated document version has been posted or referenced.
    Difference
    0.1%
    Check dated 2026-08-08T18:02:12.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4. This indicates a small platform or content update rather than a change to study details.
    Difference
    0.1%
    Check dated 2026-07-25T10:29:59.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page now displays a new revision label 'Revision: v3.6.3'. This replaces the previous 'Revision: v3.6.2' and indicates a version update of the page content.
    Difference
    0.1%
    Check dated 2026-07-03T22:53:12.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision label on the page footer was updated from v3.6.0 to v3.6.2, indicating a newer platform version. This update does not modify the study details or visible content.
    Difference
    0.1%
    Check dated 2026-06-27T01:04:34.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    A recruitment-closed banner is now displayed on the page. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) are added, and a formatting change updates 'Intervention / Treatment' to 'Intervention/Treatment' along with a revision stamp to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:28:38.000Z thumbnail image

Stay in the know with updates to Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial page.